Cited 18 times in
Lazertinib Versus Gefitinib as First-Line Treatment in Patients With EGFR-Mutated Advanced Non-Small-Cell Lung Cancer: Results From LASER301
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.